Lisata Therapeutics, Inc. (8NE.F)

3.1400 +0.0400 (+1.29%) 收市：09:24AM CEST

Lisata Therapeutics, Inc.

110 Allen Road
2nd Floor
Basking Ridge, NJ 07920
United States
908 842 0100
https://www.lisata.com

版塊: Healthcare
行業: Biotechnology
全職員工: 25

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.	President, CEO & Director	1.02M	無	1957
Dr. Kristen K. Buck M.D.	Executive VP of R&D and Chief Medical Officer	817.47k	無	1974
Mr. James Nisco	Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer	無	無	1971
Mr. Tariq Imam	Vice President of Business Development & Operations and Corporate Counsel	無	無	無
Mr. Gregory S. Berkin	Chief Information Officer	無	無	無
Mr. John D. Menditto	Vice President of Investor Relations & Corporate Communications	無	無	無
Ms. Gail Holler	Vice President of Human Resources	無	無	1959
Dr. William K. Sietsema Ph.D.	Vice President of Global Regulatory Affairs	327.04k	無	1956

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

公司管治

截至 無 止，Lisata Therapeutics, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。